筛查还是不筛查？审视反对心房颤动筛查的论据。
To Screen or Not to Screen? Examining the Arguments Against Screening for Atrial Fibrillation.
作者信息
Neubeck Lis, Orchard Jessica, Lowres Nicole, Freedman S Ben
机构信息
School of Health and Social Care, Edinburgh Napier University, Edinburgh, Scotland, UK; School of Nursing and Midwifery, Faculty of Medicine, Nursing, and Health Sciences, Flinders University, Adelaide, SA, Australia; Sydney Nursing School, Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia.
Sydney Nursing School, University of Sydney, Sydney, NSW, Australia.
出版信息
Heart Lung Circ. 2017 Sep;26(9):880-886. doi: 10.1016/j.hlc.2017.05.118. Epub 2017 May 24.
Atrial fibrillation (AF) is the most common cardiac arrhythmia, with a lifetime risk of one in four of developing AF over the age of 40 years. Around 40% of patients are asymptomatic, which is of concern as AF is a major risk factor for stroke. Early detection and appropriate management reduces stroke risk by two-thirds. Atrial fibrillation screening is now recommended in international guidelines, but there are some common arguments against screening. Overall, to be of value any screening program must fulfil the World Health Organization (WHO) Wilson and Jungner criteria for screening programs. In this paper we address the common arguments, and determine if AF screening fulfils the WHO criteria.
心房颤动（AF）是最常见的心律失常，40岁以上人群患房颤的终生风险为四分之一。约40%的患者无症状，鉴于房颤是中风的主要危险因素，这令人担忧。早期检测和适当管理可将中风风险降低三分之二。目前国际指南推荐进行心房颤动筛查，但也有一些反对筛查的常见观点。总体而言，任何筛查项目要具有价值，都必须符合世界卫生组织（WHO）针对筛查项目的威尔逊和荣格纳标准。在本文中，我们探讨这些常见观点，并确定房颤筛查是否符合WHO标准。
Zotero 插件